Skip to main content

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 11, Number 23, September 2005

Book review

Review article

Favourites:
ADD

Antiepileptics and the Treatment of Neuropathic Pain: Evidence from Animal Models
pp. 2961-2976(16)
Authors: Blackburn-Munro, G.; Erichsen, H. K.

Favourites:
ADD

NMDA Antagonists and Neuropathic Pain - Multiple Drug Targets and Multiple Uses
pp. 2977-2994(18)
Authors: Chizh, B. A.; Headley, P. M.

Favourites:
ADD

Topical Analgesics in Neuropathic Pain
pp. 2995-3004(10)
Author: Sawynok, J.

Favourites:
ADD

Sodium Channel Blockers in Neuropathic Pain
pp. 3005-3011(7)
Author: Kalso, E.

Favourites:
ADD

Opioids in Neuropathic Pain
pp. 3013-3025(13)
Authors: Przewlocki, R.; Przewlocka, B.

Favourites:
ADD

Novel Therapies for Asthma - Advances and Problems
pp. 3027-3038(12)
Author: Walsh, G. M.

Favourites:
ADD

New Insights in the Mechanism of Bone Loss in Arthritis
pp. 3039-3049(11)
Authors: Schett, G.; Smolen, J. S.

Favourites:
ADD
Favourites:
ADD

Macrophage Differentiation to Foam Cells
pp. 3061-3072(12)
Authors: Shashkin, P.; Dragulev, B.; Ley, K.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more